Pam Kessler
Analyst · RBC. Please go ahead
Thank you, Wendy. As Wendy noted, NAREIT FFO increased almost 9% from a year ago. On a diluted per share basis, FFO improved 2.6% to $0.78 on nearly 5% more weighted average diluted shares outstanding compared with last year. FFO expansion was driven primarily by top line growth of more than 10%, resulting from prior-year investments, completed development in capital improvement projects, as well as lease amendments in the latter part of 2016. Revenue growth was partially offset by higher interest expense, as a result of terming out our line of credit in 2016 and 2017, as well as the effective equity issuance under our ATM program and performance-based equity award. That increased nearly 13% due to growth drivers previously mentioned, as well as lower capitalized interest on development projects this quarter as compared to last year. During the quarter, we invested almost $9 million in various development and capital improvement projects, received a $11 million in principal payments and mortgage loan payoffs, and paid a $0.19 per share monthly common dividend. As I described on our last call, LTC took advantage of opportunities in the capital markets earlier this year, raising nearly $15 million gross proceeds under our ATM program and $100 million through the sale of senior unsecured notes to a group of institutional investors in a private placement. We used the proceeds from these transactions to pay down our line of credit and fund capital improvement and development projects. We continue to have well laddered long-term debt maturity matched to our projected free cash flow, and with no amounts currently outstanding under our line of credit, we don’t have any significant debt maturities over the next five years. Our considerable liquidity, which includes availability of more than $820 million puts LTC in an advantageous position to execute its growth strategy and quickly and decisively seize opportunities as they arise. Our availability currently includes $600 million under our line of credit, almost $37 million under our shelf agreement with Prudential and $185 million under our ATM program. We continue to strategically allocate capital where it makes the most sense for our portfolio, our partners, and our shareholders. Our capital deployment strategy will remain conservative in an effort to ensure a profitable portfolio growth. We are not interested in growth just for growth sake. LTC has long believed that closely aligning the maturities on our long-term debt with projected free cash flow is the best way to mitigate future refinancing risk. This strategy combined with a conservative releveraged balance sheet helps us maintain an investment grade credit profile. At the end of the first quarter, our credit metrics compared favorably to the healthcare REIT industry average, with a debt to annualized normalized EBITDA of 3.9 times, a normalized annualized fixed charge coverage ratio of 5 times, and a debt to enterprise value of 24.1%. Now, I’ll turn the call over to Clint for a discussion of our pipeline and portfolio metrics.